[图书][B] Goodman & Gilman's the pharmacological basis of therapeutics

LL Brunton, BC Knollmann, R Hilal-Dandan - 2018 - researchgate.net
This book presents 55 clinical cases emphasizing the basic science aspects of pathology
and is “the closest you can get to the wards without seeing patients.” Each case includes an …

Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota–gut–brain axis

MR Aburto, JF Cryan - Nature Reviews Gastroenterology & Hepatology, 2024 - nature.com
Crosstalk between gut and brain has long been appreciated in health and disease, and the
gut microbiota is a key player in communication between these two distant organs. Yet, the …

The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap

KA Walker, LM Le Page, N Terrando… - Molecular …, 2023 - Springer
Peripheral inflammation, defined as inflammation that occurs outside the central nervous
system, is an age-related phenomenon that has been identified as a risk factor for …

Transcytosis-enabled active extravasation of tumor nanomedicine

Q Zhou, J Li, J Xiang, S Shao, Z Zhou, J Tang… - Advanced Drug Delivery …, 2022 - Elsevier
Extravasation is the first step for nanomedicines in circulation to reach targeted solid tumors.
Traditional nanomedicines have been designed to extravasate into tumor interstitium …

The meningeal transcriptional response to traumatic brain injury and aging

AC Bolte, DA Shapiro, AB Dutta, WF Ma, KR Bruch… - Elife, 2023 - elifesciences.org
Emerging evidence suggests that the meningeal compartment plays instrumental roles in
various neurological disorders, however, we still lack fundamental knowledge about …

Spike proteins of SARS-CoV-2 induce pathological changes in molecular delivery and metabolic function in the brain endothelial cells

ES Kim, MT Jeon, KS Kim, S Lee, S Kim, DG Kim - Viruses, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the
coronavirus disease (COVID-19), is currently infecting millions of people worldwide and is …

[HTML][HTML] Mechanisms of NLRP3 priming in inflammaging and age related diseases

A Gritsenko, JP Green, D Brough… - Cytokine & growth factor …, 2020 - Elsevier
The NLRP3 inflammasome is a vital part of the innate immune response, whilst its aberrant
activation drives the progression of a number of non-communicable diseases. Thus, NLRP3 …

[HTML][HTML] Can exercise training teach us how to treat Alzheimer's disease?

AM Huuha, CS Norevik, JBN Moreira… - Ageing research …, 2022 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia and there is currently no
cure. Novel approaches to treat AD and curb the rapidly increasing worldwide prevalence …

Retinal vasculopathy in Alzheimer's disease

H Shi, Y Koronyo, A Rentsendorj, DT Fuchs… - Frontiers in …, 2021 - frontiersin.org
The retina has been increasingly investigated as a site of Alzheimer's disease (AD)
manifestation for over a decade. Early reports documented degeneration of retinal ganglion …

[HTML][HTML] The barrier and interface mechanisms of the brain barrier, and brain drug delivery

S Zhang, L Gan, F Cao, H Wang, P Gong, C Ma… - Brain Research …, 2022 - Elsevier
Three different barriers are formed between the cerebrovascular and the brain parenchyma:
the blood-brain barrier (BBB), the blood-cerebrospinal fluid barrier (BCSFB), and the …